Updates
Added by St. 2024, c. 342, § 36, effective April 8, 2025
Section 30
(a)
On an annual basis, each carrier shall report to the division the drugs selected to be provided with no or limited cost-sharing under section 47CCC of chapter 175, section 8DDD of chapter 176A, section 4DDD of chapter 176B and section 4VV of chapter 176G. The commissioner shall review the drugs to verify that the selected drugs meet the criteria identified in those sections. Should a selected drug be deemed by the commissioner to not meet the criteria, the commissioner may require a different drug to be selected. The commissioner shall disclose the list of drugs selected by each entity annually on the division’s website.
Contact
Online
Last updated: | January 8, 2025 |
---|